Yuyan Xu

Department of Hepatobiliary Surgery II, Southern Medical University

Affiliated withSouthern Medical University

Research Area

Biography

Yuyan Xu has not added Biography.
If you are Yuyan Xu and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 1	2025

Other Publications

Article	Year
Frizzled 2-induced epithelial-mesenchymal transition correlates with vasculogenic mimicry, stemness, and Hippo signaling in hepatocellular carcinoma. Cancer science\| PubMed ID: 30677195	2019
[Bortezomib and obatoclax for dual blockade of protein degradation pathways show synergistic anti-tumor effect in human acute T lymphoblastic leukemia cells]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University\| PubMed ID: 31068282	2019
BAP1 deletion abrogates growth and metastasis of murine cutaneous melanoma. Melanoma research\| PubMed ID: 33347048	2021
Epigenetically silenced linc00261 contributes to the metastasis of hepatocellular carcinoma via inducing the deficiency of FOXA2 transcription. American journal of cancer research\| PubMed ID: 33520374	2021
BAP1 loss augments sensitivity to BET inhibitors in cancer cells. Acta pharmacologica Sinica\| PubMed ID: 34737422	2022
TGF-β1 induced deficiency of linc00261 promotes epithelial-mesenchymal-transition and stemness of hepatocellular carcinoma via modulating SMAD3. Journal of translational medicine\| PubMed ID: 35123494	2022
Histone Acetylation Regulator-Mediated Acetylation Patterns Define Tumor Malignant Pathways and Tumor Microenvironment in Hepatocellular Carcinoma. Frontiers in immunology\| PubMed ID: 35145517	2022
Multiomics analyses and machine learning of nuclear receptor coactivator 6 reveal its essential role in hepatocellular carcinoma. Cancer science\| PubMed ID: 36086920	2023
Case report: Primary hepatocellular carcinoma with portal vein tumor thrombus characterized by active tumor immune microenvironment achieving a complete response following treatment of combi... Frontiers in immunology\| PubMed ID: 36119069	2022
H4-methylation regulators mediated epitranscriptome patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma. Clinical epigenetics\| PubMed ID: 36932439	2023
Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection. Frontiers in oncology\| PubMed ID: 36959801	2023
Mannose-Binding Lectin 2 as a Potential Therapeutic Target for Hepatocellular Carcinoma: Multi-Omics Analysis and Experimental Validation. Cancers\| PubMed ID: 37835594	2023
Serum micro-RNAs with mutation-targeted RNA modification: a potent cancer detection tool constructed using an optimized machine learning workflow. Scientific reports\| PubMed ID: 38641707	2024
Constructing diagnostic signature of serum microRNAs using machine learning for early pan-cancer detection. Discover oncology\| PubMed ID: 38965104	2024
A N7-methylguanosine modified circular RNA, circIPP2A2, promotes malignant behaviors in hepatocellular carcinoma by serving as a scaffold in modulating the Hornerin/PI3K/AKT/GSK3β axis. Cell death & disease\| PubMed ID: 39616161	2024
Cancer specific up-regulated lactate genes associated with immunotherapy resistance in a pan-cancer analysis. Heliyon\| PubMed ID: 39669156	2024